53 studies found for:    (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Unknown  The Safety and Immunogenicity of a Potential HIV Vaccine
Condition: HIV Infections
Intervention: Biological: CN54gp140 mixed with GLA-AF
22 Recruiting Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX®-GP HIV-1 DNA vaccine;   Biological: Interleukin-12 (IL-12) DNA adjuvant;   Biological: Placebo
23 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
24 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Interventions: Biological: Gardasil;   Drug: Placebo
25 Not yet recruiting REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study
Condition: HIV/AIDS
Intervention: Biological: REMUNE
26 Recruiting The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo
Condition: HIV
Interventions: Biological: GTU®-MultiHIV B Clade Vaccine;   Other: Sodium chloride BP
27 Recruiting Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Condition: Smallpox
Intervention: Biological: IMVAMUNE®
28 Recruiting Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: Placebo
29 Unknown  Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
30 Unknown  Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes
Condition: HIV
Intervention: Biological: GTU®-multiHIV B clade
31 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
32 Recruiting A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination
Conditions: Hepatitis C Infection;   HIV Infection
Interventions: Biological: AdCh3NSmut1;   Biological: MVA-NSmut;   Biological: ChAdV63.HIVconsv;   Biological: MVA.HIVconsv
33 Unknown  Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses
Condition: HIV
Interventions: Biological: DNA;   Biological: MVA-C;   Biological: CN54rgp140;   Biological: GLA-AF
34 Recruiting Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .
Conditions: Hepatitis B;   HIV
Intervention: Biological: Recombinant Hepatitis B Virus Vaccine
35 Unknown  Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Conditions: HIV Infections;   Hepatitis A;   Hepatitis B
Interventions: Biological: Twinrix;   Biological: interleukin-2
36 Recruiting A T Cell-based HIV Vaccine
Condition: HIV
Interventions: Other: HIV positive subjects;   Other: Non-infected control subjects
37 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
38 Not yet recruiting Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers
Condition: HIV
Interventions: Biological: DNA-C CN54ENV;   Biological: CN54gp140;   Device: Trigrid Delivery System - Intramuscular;   Device: Trigrid Delivery System - Intradermal
39 Recruiting Research In Viral Eradication of HIV Reservoirs
Condition: HIV
Interventions: Drug: Combination Antiretroviral Therapy (cART);   Drug: Raltegravir;   Drug: Vorinostat;   Biological: ChAdV63.HIVconsv (ChAd);   Biological: MVA.HIVconsv (MVA)
40 Recruiting Zambia SiVET MMR Tdap-IPV
Condition: High Risk for HIV
Interventions: Biological: Tdap - IPV Vaccine;   Biological: MMR Vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-53) Show next page of results    Last Page
Indicates status has not been verified in more than two years